The global animal health market was valued at USD 41.50 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.3%, reaching USD 97.54 billion by 2032. In 2018, North America led the market, accounting for 34.02% of the global share.
Animal healthcare focuses on ensuring the well-being of animals through the use of drugs, vaccines, medicated feeds, and diagnostic tools to address various medical conditions. Animals play a vital role in human life by providing food, security, and companionship.
Read More :Â https://www.fortunebusinessinsights.com/animal-health-market-102371Â
Key Industry Development
In January 2021, Boehringer Ingelheim, a leader in animal health, announced a strategic partnership with PetMedix to advance the development of antibody therapeutics for companion animals. This collaboration leverages PetMedix’s proprietary Ky9 platform for antibody discovery and will focus on addressing vital therapeutic targets. Boehringer Ingelheim is responsible for bringing these groundbreaking therapies to market, marking a significant step in the evolution of animal healthcare.
Top Companies in the Animal Health Market
- Zoetis
- Intervet International B.V.
- Elanco
- Ceva
- Virbac
- Merck & Co., Inc.
- Novartis AG
- Emergent BioSolutions, Inc.
- CSL Limited
- IDEXX Laboratories, Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
Market Drivers & Restraints
The animal health market is driven by the increasing prevalence of zoonotic diseases, rising pet ownership, and advancements in veterinary healthcare technologies. The growing awareness about animal welfare and demand for high-quality protein sources also fuel market growth. However, factors such as stringent regulatory requirements and high costs associated with veterinary services may restrain the market’s expansion.
Market Report Coverage
The comprehensive market report covers various aspects, including market size, growth trends, competitive landscape, key players, and regional insights. It provides a detailed analysis of the factors influencing the market and forecasts future developments in the animal health industry.
Market Competitive Landscape
The animal health market is highly competitive, with major players continually innovating to stay ahead. Companies are focusing on partnerships, acquisitions, and R&D investments to expand their portfolios and strengthen their market positions. The emergence of advanced diagnostic tools and therapeutic solutions is reshaping the competitive dynamics.
Market Segments
The drugs segment is the leading segment in the global animal health market. This dominance is attributed to the increasing demand for effective veterinary medicines and the continuous development of new drug formulations to address various animal health issues.
Market Regional Insights
North America leads the global animal health market, driven by the region’s advanced veterinary infrastructure and high pet adoption rates. Europe and Asia-Pacific also hold significant market shares, with Asia-Pacific experiencing rapid growth due to increasing livestock population and rising awareness of animal health. Emerging markets in Latin America and the Middle East are also witnessing growth, supported by economic development and expanding veterinary services.
Future Market Scope
The future of the animal health market is promising, with increasing investments in research and innovation. The adoption of digital technologies, such as telemedicine and wearable devices for animals, is expected to transform the industry. Furthermore, the rising focus on sustainable and preventive animal healthcare solutions will create new opportunities for growth. As the global demand for animal-based products continues to rise, the market is poised for sustained expansion.
